Cuvposa Available for Chronic Severe Drooling Associated with Neurologic Conditions

CUVPOSA (glycopyrrolate) 1mg/5mL liquid by Shionogi
CUVPOSA (glycopyrrolate) 1mg/5mL liquid by Shionogi
Cuvposa (glycopyrrolate liquid; Shionogi) has been made available for the treatment of chronic severe drooling associated with neurologic conditions (eg, cerebral palsy) in patients 3–16 years of age. Cuvposa was first approved by the FDA in July 2010.

Cuvposa is available as a cherry flavored oral solution in a 1mg/5mL concentration.

For more information call (973) 966-6900 or visit www.cuvposa.com.